2C-P: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
Assign pharmacological categories from List_of_CNS-active_medicines |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid)"> | |||
Erowid's dosage documentation for oral 2C-P<ref name="erowid-2cp-dose"> | |||
Erowid. 2C-P Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/2cp/2cp_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers: | |||
* '''Light:''' 2-5 mg | |||
* '''Common:''' 6-10 mg | |||
* '''Strong:''' 10-16 mg | |||
* '''Heavy:''' 16+ mg | |||
Threshold not characterized. Timing data not provided by Erowid. Erowid | |||
explicitly warns that 2C-P has a steep dose-response curve with very small | |||
margin between a manageable dose and an overdose; this medicine has been | |||
associated with severe adverse events and fatalities at doses only modestly | |||
above the common range. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||
| Line 32: | Line 50: | ||
[[Category:Research | [[Category:Research chemicals]] | ||
[[Category:Phenethylamines]] | [[Category:Phenethylamines]] | ||
[[Category: | [[Category:2C-x series]] | ||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Psychedelics]] | |||